Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | All patients in the study will be treated with ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 2 | Continued Ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 3 | OCRELIZUMAB | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 13 13, 46, 49 |
| 4 | Ocrelizumab (CinnaGen, Iran) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 5 | Ocrelizumab (Roche, Switzerland) | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 6 | Ocrelizumab / rhuMAb 2H7 | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
| 7 | Ocrelizumab 300 mg | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 8 | Ocrelizumab 300mg | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 9 | Ocrelizumab 300mg /10ml | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 10 | Ocrelizumab 300mg/10 ml | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 11 | Ocrelizumab 300mg/10ml | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 12 | Ocrelizumab 500mg | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
| 13 | Ocrelizumab 600 mg | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 14 | Ocrelizumab at home | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 15 | Ocrelizumab Dose 1 | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 16 | Ocrelizumab Dose 2 and Dose 3 | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 17 | Ocrelizumab IV | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 18 | Ocrelizumab SC | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 19 | Ocrelizumabu 200mg | - | - | - | - | 1件: 46 46 |
| 20 | Ocrelizumabu 50mg | - | - | - | - | 1件: 46 46 |
| 21 | Other: Observation of Ocrelizumab as Treatment in RRMS Patients | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 22 | Other: Ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
| 23 | Short-course Ocrelizumab | 1件: Ocrelizumab Ocrelizumab | 1件: D05218
D05218
(Name: Ocrelizumab) | 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |